Patent · US Active

c-MYC mRNA translation modulators and uses thereof in the treatment of cancer

US12404283B2 · kind B2 · utility

0Cited by

2References

38Claims

0Family size

Assignee

Anima Biotech Inc. · US

Inventors

Aviad MANDABI · Ramat Gan, IL
Boaz Inbal · Modiin-Maccabim-Reut, IL
Scott SADLER · Ramat Gan, IL
Shuyu Chu · Ramat Gan, IL
David William SHEPPARD · Ramat Gan, IL
Jason Tierney · Saffron Walden, GB
Iris Alroy · Nes Ziona, IL
Rina WASSERMANN · Ramat Gan, IL
Yoni SHEINBERGER · Ramat Gan, IL
Yaode Wang · Beijing, CN
Haitang Li · Beijing, CN
Lothar Willms · Hillscheid, DE

Key dates

Filing date	Jul 2, 2023
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Jul 2, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel c-MYC mRNA translation modulators, composition and methods of preparation thereof, and uses thereof in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.